Gene therapy: the end of the rainbow?

Edward J Shillitoe1

  • 1Department of Microbiology & Immunology, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA. shillite@upstate.edu

Head & Neck Oncology
|April 1, 2009
PubMed

Insights

Gene therapy for oral cancer shows promise but faces challenges. Current virus vectors are temporary; replicating viruses could offer a breakthrough for effective, long-term oral cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Significant advancements in understanding oral cancer molecular genetics.
  • Gene therapy holds potential for improved oral cancer treatments.
  • Despite 20 years of clinical trials, routine gene therapy for oral cancer is unavailable.

Purpose of the Study:

  • To review the progress and challenges in oral cancer gene therapy.
  • To identify key obstacles hindering the clinical application of gene therapy for oral cancer.
  • To explore future directions for effective oral cancer gene therapy.

Main Methods:

  • Review of existing literature on oral cancer gene therapy clinical trials.
  • Analysis of viral vector limitations in gene delivery for cancer treatment.
  • Examination of research into replicating viral vectors for enhanced gene therapy efficacy.

Main Results:

  • Current gene delivery methods using non-replicating virus vectors have shown weak and temporary effects.
  • The development of replicating viruses presents a promising avenue for more potent and sustained gene therapy.
  • Significant challenges remain in translating research findings into effective patient treatments.

Conclusions:

  • Effective gene therapy for oral cancer remains a distant goal without substantial breakthroughs.
  • The development of safe and effective replicating viral vectors is crucial for the future of oral cancer gene therapy.
  • Continued research into advanced gene delivery systems is essential to overcome current limitations.

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
What is Genetic Engineering?00:49

What is Genetic Engineering?

Overview
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...